Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 May 2003

Concentration of prothrombin fragment 1+2 (F1+2)in patients with liver cirrhosis and chronic hepatitis C infection

H. Fota-Markowska, R. Modrzewska, J. Krzowska-Firych, J. Lis-Tonder

Med Sci Monit 2003; 9(2): 8-0 :: ID: 15227

Abstract

Background:Appreciation of serum concentration of prothrombin complex factors is a very sensitive indicator of liver synthesis activity.It is also a very valuable way to estimate the stage and seriousness of inflammatory processes,a toxic damage and the cirrhosis of liver.The aim of this study was to assess the serum concentration of F1+2 in patients with liver cirrhosis developed during HCV infection and in patients with chronic hepatitis C infection.Material/Methods:The study group consisted of 52 patients hospitalised at the Department of Infectious Diseases of Medical University of Lublin, Poland. Among them,18 patients (8 men and 10 women),aged 19 –59 years,had a stable liver cirrhosis and 34 patients (21 men and 13 women),aged 20 –41 years,were diagnosed with chronic hepatitis C infection.The diagnosis of liver cirrhosis in the course of HCV infection was made on the presence of HCV RNA in serum in RT-PCR and on the liver biopsy results in Child-Plough classification.All patients with CHC met the criteria for standard antiviral therapy and they began to be treated with interferon alpha and Ribavirin,without having any concomitant diseases.The control group consisted of 25 healthy individuals (13 men and 12 women),aged 19 –60 years.Blood samples were obtained from ulnar veins of patients being on empty stomach into the tubes containing 3.8%solution of citric acid diluted 1:10.They were then centrifuged for 15 minutes at the speed of 1500/min and room temperature.The plasma was kept at a temperature of –40 °C before being tested.The serum concentration of F1+2 was determined by the immunoenzymatic assay Enzygnost F1+2 micro.The obtained data were statistically evaluated with Kolmogorow-Smirnow test assuming 5%risk of conclusion error. Results:The serum concentration of F1+2 was 1.1+0.6 nmol/l in the control group,1.078+0.485 nmol/l in the cirrhotic patients and 1.438+784 nmol/l in the patients with CHC. There were no statistically significant differences in the serum concentration of F1+2 between cirrhotic patients and controls (p>0.05).Similarly,the differences observed in the F1+2 levels in patients with CHC and controls were not statistically important (p>0.05).No statistically significant differences were observed in the F1+2 serum concentration between patients with cirrhosis and CHC (p>0.05).In general,elevated serum levels of F1+2,above 1.7 nmol/l,were observed in every third patient, however, more often in patients with CHC (35.3%) than in cirrhotic patients (16.7%). Conclusions: 1.There were no statistically significant differences observed in serum concentration of F1+2,both in patients with stable cirrhosis and with CHC,compared to controls.2.However in 16.7%of patients with cirrhosis and in 35.3%of patients with CHC elevated serum levels of F1+2 were observed.

Keywords: prothrombin fragment 1+2 (F1+2), Liver Cirrhosis, chronic hepatitis C infection

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750